Abstract
The therapeutic utility of recombinant adenoviruses (rAds) is limited in part by difficulties in directing the viruses to specific sites and by the requirement for bolus administration, both of which limit the efficiency of target tissue infection. As a first step toward overcoming these limitations, rAds were encapsulated in coacervate microspheres comprised of gelatin and alginate followed by stabilization with calcium ions. Ultrastructural evaluation showed that the microspheres formed in this manner were 0.8–10 μM in diameter, with viruses evenly distributed. The microspheres achieved a sustained release of adenovirus with a nominal loss of bioactivity. The pattern of release and the total amount of virus released was modified by changes in microsphere formulation. Administration of the adenovirus-containing microspheres to human tumor nodules engrafted in mice showed that the viral transgene was transferred to the tumor cells. It is concluded that coacervate microspheres can be used to encapsulate bioactive rAd and release it in a time-dependent manner.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kalyanasundaram, S., Feinstein, S., Nicholson, J. et al. Coacervate microspheres as carriers of recombinant adenoviruses. Cancer Gene Ther 6, 107–112 (1999). https://doi.org/10.1038/sj.cgt.7700025
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.cgt.7700025
Keywords
This article is cited by
-
Adenoviral Gene Delivery to Solid Tumors by Recombinant Silk–Elastinlike Protein Polymers
Pharmaceutical Research (2007)
-
A direct mechanical method for accurate and efficient adenoviral vector delivery to tissues
Gene Therapy (2003)
-
Localized adenovirus gene delivery using antiviral IgG complexation
Gene Therapy (2001)